Literature DB >> 10933749

Effect of acarbose administration on plasma concentrations of zinc and copper in patients with NIDDM.

Y M Song1, M D Chen, W H Sheu.   

Abstract

Acarbose reduces the intestinal absorption of dietary carbohydrate, thereby ameliorating postprandial hyperglycemia in diabetes mellitus. Dietary carbohydrate can modulate the bioavailability of some trace minerals like zinc and copper. Deficiencies in these minerals are associated with glucose intolerance. It is still unknown whether acarbose's reduction of intestinal carbohydrate absorption causes the short supply of these minerals. Thus, we investigated the changes in plasma zinc and copper levels in patients with NIDDM, after administration of acarbose for 3 months. The results showed that acarbose did not significantly affect fasting and postprandial plasma levels of these minerals, even after acarbose withdrawal. This study indicated that acarbose administration in NIDDM patients over a 3-month period does not influence plasma levels of zinc or copper.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933749

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  2 in total

1.  A cross-sectional study of the correlation between diabetic therapy and serum zinc concentrations.

Authors:  Mamoru Sakurai; Junko Sasaki; Hirotsugu Suwanai; Jumpei Shikuma; Rokuro Ito; Masato Odawara; Takashi Miwa; Ryo Suzuki
Journal:  Diabetol Int       Date:  2021-07-10

2.  The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24).

Authors:  Xue-Lian Zhang; Shen-Yuan Yuan; Gang Wan; Ming-Xia Yuan; Guang-Ran Yang; Han-Jing Fu; Liang-Xiang Zhu; Jian-Dong Zhang; Yu-Ling Li; Da-Yong Gao; Xue-Li Cui; Zi-Ming Wang; Rong-Rong Xie; Ying-Jun Chen
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.